Research Article
Laparoscopic versus Open Complete Mesocolic Excision for Right
Colon Cancer
Ali Zedan ,
1
Essam Elshiekh,
2
MohamedIOmar ,
1
Mohamad Raafat,
3
Salah M. Khallaf,
4
Haisam Atta,
5
and Marwa T. Hussien
6
1
Department of Surgical Oncology, South Egypt Cancer Institute, Assiut University, Asyut, Egypt
2
Department of Surgical Oncology, Tanta Cancer Center, Tanta, Egypt
3
Department of General Surgery, Faculty of Medicine, Assiut University, Asyut, Egypt
4
Department of Medical Oncology, South Egypt Cancer Institute, Assiut University, Asyut, Egypt
5
Department of Diagnostic Radiology, South Egypt Cancer Institute, Assiut University, Asyut, Egypt
6
Department of Oncologic Pathology, South Egypt Cancer Institute, Assiut University, Asyut, Egypt
Correspondence should be addressed to Ali Zedan; alizedan73@yahoo.com
Received 27 July 2020; Revised 17 January 2021; Accepted 22 January 2021; Published 2 February 2021
Academic Editor: C. H. Yip
Copyright © 2021 Ali Zedan et al. is is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background and Objectives. e use of complete mesocolic excision (CME) technique seems to be gaining popularity in the
management of cancer colon. We aim to compare the laparoscopic approach for CME with the open approach in right colon
cancer treatment with regard to the feasibility, safety, and perioperative and oncologic outcomes. Patients and Methods.A
prospective study which included all patients that underwent radical right hemicolectomy for pathologic confirmed stage II or
stage III tumor with CME at South Egypt Cancer Institute, Assiut University, from January 2012 to December 2019. Patients were
grouped according to the surgical approach into the laparoscopic colectomy (LCME) group (n � 48) or open colectomy (OCME)
group (n � 48). Results. e mean operative time was significantly longer in the LCME group than that in the OCME group with
less mean intraoperative blood loss. Conversion was required in 4 patients (8.3%) in the LCME group. e use of laparoscopy
increased the number of harvested lymph nodes compared to the open approach (39.81 ± 16.74 vs. 32.65 ± 12.28, respectively,
P � 0.010). e laparoscopic approach was associated with a shorter time interval to first flatus as well as shorter time interval to
liquid and normal diet after surgery. e postoperative hospital stay was significantly shorter in the LCME group. e com-
plication rate was slightly lower in the LCME (14.7%) than in the OCME group (27.2%) (P � 0.252). e 3-year OS in the LCME
group was similar to that in OCME (78.2% vs. 63.2%, respectively, P value � 0.423). e three-year DFS in the laparoscopic group
was higher (74.5%) than the open group (60.0%), but did not reach statistical significance (P value � 0.266). Conclusions. In
conclusion, laparoscopic CME right hemicolectomy is a technically feasible and safe procedure if surgeon expertise is present.
LCME has long-term oncologic outcomes (recurrence and survival) comparable to open surgery for management of patients with
stage II or III colon cancer.
1. Introduction
In 2009, Dr. Hohenberger first proposed the concept of
complete mesocolic excision (CME) for colon cancer sur-
gery [1] according to the concept of total mesorectal excision
(TME) for rectal cancer. e technique of CME relies on
three key components: (I) sharp dissection in the
embryologic plane between the parietal fascia and visceral
(mesenteric) fascia to remove mesentery together with its
lymphatic drainage as an intact envelope [2]; the principle
behind this technique is to avoid any inadvertent exfoliation
of the tumor cells from mesentery into the peritoneal cavity;
(II) proximal ligation of feeding vessels at their origin to
remove apical lymph nodes; and (III) resection of a sufficient
length of bowel to remove potentially involved lymph nodes
in a longitudinal direction [3].
After postulation of CME technique, CME with central
vascular ligation (CVL) has been applied by many European
Hindawi
International Journal of Surgical Oncology
Volume 2021, Article ID 8859879, 8 pages
https://doi.org/10.1155/2021/8859879